BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 23, 2004
View Archived Issues
Bringing In IL13 Phase III Trial Support, NeoPharm Gets $68.4M
NeoPharm Inc. intends to use proceeds from a $68.4 million public offering to advance its cancer agent for malignant glioma. (BioWorld Today)
Read More
Genaera Gains $20M Through Direct Stock Equity Placement
Read More
Childhood Brain Tumor Growth With Neurofibromatosis Needs Abnormal Cellular Neighbors In Mouse Model
Read More
NIH Director In Senate Hot Seat Over Employee Disclosure Rules
Read More
Other News To Note
Read More